Navigation Links
Jennerex Appoints James M. Burke, M.D. Vice President, Clinical Research
Date:2/22/2011

wn University and his B.S. in biochemistry and cell biology from the University of California, San Diego. He is the author of more than 10 key publications and presentations detailing the use of gene therapy and oncolytic viruses to treat cancer. He is board certified in hematology, oncology and internal medicine.

About Jennerex

Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594 is currently in two Phase 2 clinical trials in patients with primary liver cancer—an international, randomized, Phase 2 clinical trial, and a Phase 2 study of JX-594 in combination with sorafenib. Published studies designed to establish optimal dose levels and the safety profile of JX-594 have shown its ability to selectively target and cause destruction of a variety of common cancer types. JX-594 and other product candidates under development are designed to attack cancer tumors through three diverse mechanisms of action: the lysis of cancer cells through viral replication, the ablation of the blood supply to tumors through vascular targeting and destruction and the stimulation of the body's immune response against the cancer. Jennerex is headquartered in San Francisco and has related research and development operations in Ottawa, Canada and Pusan, South Korea. For more information about Jennerex, please visit www.jennerex.com.


'/>"/>
SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
2. Jennerex Completes Fully Subscribed Private Placement for Aggregate Gross Proceeds of $8.6 Million
3. Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously
4. Jennerex Adds Industry Veteran Paul Cleveland to Board of Directors
5. Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million
6. Jennerex Closes $5 Million First Tranche of Series C Financing
7. Nature Reviews Publishes Article About Jennerexs Multi-Mechanistic Cancer Therapeutic
8. Jennerex Appoints Samantha Miller as Vice President of Corporate Development
9. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
10. ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors
11. Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... September 23, 2014Researchers from the University of Texas ... new method to improve the reliability and performance ... (CNT), a semiconductor material that has long been ... promising successors to silicon for smaller, faster and ... new paper published in the journal Applied ...
(Date:9/23/2014)... September 23, 2014 Kamal Rashid ... Biomanufacturing Education and Training Center (BETC) and research professor ... BioTalk 2014 , an international two-day event focused ... Sponsored by Global Summits, the event will bring together ... living cells to develop and produce human therapeutics. “The ...
(Date:9/23/2014)... DUBLIN , Sept. 23, 2014 ... of the "Proteomics Markets for Research and ... Other Technologies)" report to their offering. ... trends for proteomics applications, both in their research ... of proteins, including the study of the structure ...
(Date:9/23/2014)... 23, 2014 Follow us ... steady popularity the world over, due to its ... in the marketplace is expected to come from ... developing countries. Several sub-Saharan countries in the African ... already implemented genetically engineered crop production strategies. Rising ...
Breaking Biology Technology:Future flexible electronics based on carbon nanotubes 2Future flexible electronics based on carbon nanotubes 3Future flexible electronics based on carbon nanotubes 4Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 4Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
... NIOX MINO(R) Set to Dramatically Improve Airway Inflammatory Disease ... Management through Personalized Inflammation Control, NEW PROVIDENCE, N.J., ... that NIOX MINO (http://www.nioxmino.com ), a,hand- held point-of-care ... cleared by the U.S. Food and Drug Administration (FDA).,Physicians ...
... RICHMOND, Va., March 4 Insmed Inc. (Nasdaq,CM: INSM), a developer of ... December 31, 2007., Full-Year 2007 and Recent Company Highlights, ... Completed development of INS-19 (Granulocyte Colony Stimulating ... these products to ...
... First Joint U.S. National Modeling and ... Simulation Meeting on March 11-12, 2008, ... PHST ), a leading provider of software, strategic,consulting, ... its broad-based participation at the inaugural,meeting of the American ...
Cached Biology Technology:FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 2FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 3FDA Grants Market Clearance to Aerocrine Inc.'s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma 4Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 2Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 3Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 4Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 5Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 6Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 7Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 8Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 9Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 10Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results 11Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics 2Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics 3
(Date:9/23/2014)... or isoforms in microRNAs (miRNAs) before, but assumed that ... in the journal Oncotarget this month, shows ... on geographic subpopulations and gender and that the most ... the one typically listed in the public databases. , ... common than we had previously assumed. The fact that ...
(Date:9/23/2014)... When the body forms new tissues during the ... with each other. For years, scientists believed this ... at Carnegie Mellon University and the University of ... communication is equally if not more crucial. ... the Proceedings of the National Academy of ...
(Date:9/23/2014)... Research by Rice University scientists who are fighting a ... be a clinician,s most powerful ally. , "Recent research ... cyberwarfare against the immune system, and we studied the ... how we might turn the tables on cancer," said ... this week in the Early Edition of the ...
Breaking Biology News(10 mins):Slight alterations in microRNA sequences hold more information than previously thought 2Slight alterations in microRNA sequences hold more information than previously thought 3The mechanics of tissue growth 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3
... single female is nearby, female antbirds will sing over the ... keep their messages from getting through, according to a new ... , a Cell Press publication. Males respond to that interruption ... first evidence that such "signal jamming" and "jamming avoidance" occur ...
... at Birmingham professor Lisa Guay-Woodford, M.D., will receive ... Jean Kaplan International Prize for Advancement in the ... The PKD Foundation and the International Society of ... contributions to the field of polycystic kidney disease ...
... of who will carry the burden but could instead ... economic modeling presented today at "Climate Change: Global Risks, ... Contrary to current cost models for lowering ... of researchers from the University of Cambridge conclude that ...
Cached Biology News:Female birds 'jam' their mates' flirtatious songs 2UAB's Lisa Guay-Woodford earns top international nephrology prize 2UAB's Lisa Guay-Woodford earns top international nephrology prize 3Fighting global warming offers growth and development opportunities 2Fighting global warming offers growth and development opportunities 3
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
Mouse monoclonal [CRC64] to Integrin alpha 2b + beta 3 ( Abpromise for all tested applications). Antigen: Human platelets Entrez Gene ID: 23295 Swiss Protein ID: P05106...
PFM8 Antibody...
Biology Products: